PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis
Clinical trial NCT03415711 · TERMINATED
Trial details
- NCT number
- NCT03415711
- Sponsor
- VSL Pharmaceuticals
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2019-04-24
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.